AA 673

Known as: AA-673 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-1989
012319851989

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The pharmacodynamics of Amlexanox (AA-673), an azoxanthone derivative recently developed as an ocular anti-allergic drug, were… (More)
Is this relevant?
1989
1989
The inhibitory effect of 0.25% AA-673 eye drops on histamine release in tears was examined by an ocular provocation test with… (More)
Is this relevant?
1989
1989
The effect of amlexanox on the non-immunological or immunological release of histamine or leukotrienes (LTs) from passively… (More)
Is this relevant?
1989
1989
The influences of anti-allergic drugs on superoxide generation from the hypoxanthine-xanthine oxidase system or polymorphonuclear… (More)
Is this relevant?
1987
1987
Amlexanox markedly inhibits histamine release from rat mast cells. To clarify the mechanism of this inhibition, we investigated… (More)
Is this relevant?
1985
1985
Amoxanox inhibited immunologically stimulated and LTD4-induced bronchoconstriction in laboratory animals. Amoxanox, like DSCG… (More)
Is this relevant?
1985
1985
We studied the effects of amoxanox (AA-673) on allergic asthma and spasmogen-induced bronchoconstriction in guinea pigs and rats… (More)
Is this relevant?